David Piacquad - 14 Sep 2023 Form 3 Insider Report for Neumora Therapeutics, Inc. (NMRA)

Role
Director
Signature
/s/ Joshua Pinto, as Attorney-in-Fact for David Piacquad
Issuer symbol
NMRA
Transactions as of
14 Sep 2023
Net transactions value
$0
Form type
3
Filing time
14 Sep 2023, 19:06:29 UTC
Next filing
14 Jun 2024

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney